Table 1.
Clinical characteristics of HIV-infected and uninfected women
| Characteristic | Valuea for: |
|
|---|---|---|
| HIV-infected women | Uninfected women | |
| No. of women | 39 | 47 |
| Age, yr [median (IQR)] | 36.0 (29–39) | 38.0 (30–46) |
| No. of women on antiretroviral therapy (%) | 14 (36) | ND |
| Absolute blood CD4 count, cells/μl [median (IQR)] | 382 (262–529) | ND |
| CD3+ T cells per single cervical cytobrush [median (IQR)] | 125,600 (76,000–209,200) | 126,800 (59,800–201,600) |
| Cervical viral load, RNA copies/ml [median (IQR)] | 70 (70–330) | ND |
| Plasma viral load, RNA copies/ml [median (IQR)] | 2,700 (50–39,250) | ND |
| No. of women with detectable plasma viral load (%) | 19/34b (56) | ND |
| Viral load in women with detectable levels, RNA copies/ml [median (IQR)] | 31,000 (5,000–150,000) | ND |
| Range of plasma viral load in women with detectable levels (RNA copies/ml) | 180–760,000 | ND |
| No. of women with detectable cervical viral load (%) | 9/30c (30) | ND |
| Cervical viral load in women with detectable levels, RNA copies/ml [median (IQR)] | 2,000 (370–2,700) | ND |
| Range of cervical viral load in women with detectable levels (RNA copies/ml) | 110–9,300 | ND |
a
ND, not determined.
b
Plasma samples were available for viral load assessment from only 34 of the 39 HIV-infected women.
c
Cervical samples for evaluation of cervical viral loads were available from only 30 of the 39 HIV-infected women.